| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65862-134-99 | 65862-134 | HUMAN PRESCRIPTION DRUG | Hydrochlorothiazide | Hydrochlorothiazide | TABLET | ORAL | 20070720 | N/A | ANDA | ANDA040780 | Aurobindo Pharma Limited | HYDROCHLOROTHIAZIDE | 50 mg/1 | 1000 TABLET in 1 BOTTLE (65862-134-99) |
| 65862-134-01 | 65862-134 | HUMAN PRESCRIPTION DRUG | Hydrochlorothiazide | Hydrochlorothiazide | TABLET | ORAL | 20070720 | N/A | ANDA | ANDA040780 | Aurobindo Pharma Limited | HYDROCHLOROTHIAZIDE | 50 mg/1 | 100 TABLET in 1 BOTTLE (65862-134-01) |
| 65862-133-99 | 65862-133 | HUMAN PRESCRIPTION DRUG | Hydrochlorothiazide | Hydrochlorothiazide | TABLET | ORAL | 20070720 | N/A | ANDA | ANDA040780 | Aurobindo Pharma Limited | HYDROCHLOROTHIAZIDE | 25 mg/1 | 1000 TABLET in 1 BOTTLE (65862-133-99) |
| 65862-133-01 | 65862-133 | HUMAN PRESCRIPTION DRUG | Hydrochlorothiazide | Hydrochlorothiazide | TABLET | ORAL | 20070720 | N/A | ANDA | ANDA040780 | Aurobindo Pharma Limited | HYDROCHLOROTHIAZIDE | 25 mg/1 | 100 TABLET in 1 BOTTLE (65862-133-01) |